Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

Wu S, Zhao J, Azmi AA, Gupte A, Thibodeau J, Liu S, Yang J, Wang G, Edwards H, Polin LA, Kushner J, Dzinic SH, White K, Boerner J, Hüttemann M, Yang J, Wang Y, Taub JW, Ge Y

Open source

DOI: 10.1002/1878-0261.70124
Published: 2026 Feb
Container: Molecular oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/1878-0261.70124,
  title = {Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.},
  author = {Wu S and Zhao J and Azmi AA and Gupte A and Thibodeau J and Liu S and Yang J and Wang G and Edwards H and Polin LA and Kushner J and Dzinic SH and White K and Boerner J and Hüttemann M and Yang J and Wang Y and Taub JW and Ge Y},
  year = {2026},
  journal = {Molecular oncology},
  doi = {10.1002/1878-0261.70124},
  url = {https://doi.org/10.1002/1878-0261.70124}
}

RIS

TY  - JOUR
TI  - Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.
AU  - Wu S
AU  - Zhao J
AU  - Azmi AA
AU  - Gupte A
AU  - Thibodeau J
AU  - Liu S
AU  - Yang J
AU  - Wang G
AU  - Edwards H
AU  - Polin LA
AU  - Kushner J
AU  - Dzinic SH
AU  - White K
AU  - Boerner J
AU  - Hüttemann M
AU  - Yang J
AU  - Wang Y
AU  - Taub JW
AU  - Ge Y
PY  - 2026
JO  - Molecular oncology
DO  - 10.1002/1878-0261.70124
UR  - https://doi.org/10.1002/1878-0261.70124
ER  -

APA

S, W., J, Z., AA, A., A, G., J, T., S, L., J, Y., G, W., H, E., LA, P., J, K., SH, D., K, W., J, B., M, H., J, Y., Y, W., JW, T., & Y, G. (2026). Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.. Molecular oncology. https://doi.org/10.1002/1878-0261.70124

Source records

pubmed · retrieved 2026-09-26T05:41:48.960Z